ArticleAlimentary pharmacology & therapeutics2022

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study.

Daniela Pugliese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.